EUVIMEDEUVIMED entdecken
Crossref

Luteolin/ ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA ‐124 by targeting C/ EBPA

Enas M Moustafa iD, Fatma S M Moawed iD, Dina F Elmaghraby

Environmental Toxicology · 2023

DOI: 10.1002/tox.23903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Enas M Moustafa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Biology, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Insulins, MicroRNAs, Neuroinflammatory Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The most prevalent brain‐specific microRNA, MicroRNA‐124, exhibits anti‐inflammatory properties. Luteolin nano‐formulation with Zn oxide in the form of L/ZnO NPs may boost anti‐diabetic properties; however, its beneficial effect on miRNAs is yet unknown in diabetes. The effectiveness of L/ZnONPs supplements in preventing diabetic neurodegeneration by modulating inflammatory responses in a diabetic model was investigated.

Methods

A diabetic rat model was induced by a high‐fat diet and streptozotocin (30 mg/kg I.P.). Plasma glucose, insulin, and HOMR‐IR levels, as well as cytokines, lipid peroxidation, GSH/GSSG, and glucose transporter 1, were determined along with the tight junction proteins occludin (OCLN) and zona occludens 1 (ZO‐1). Moreover, the expressions of brain CCAAT/enhancer‐binding protein (C/EBPA mRNA), miR‐124, glial fibrillary acidic protein (GFAP), and NF‐kBp65 were measured alongside the histological investigation.

Results

The results revealed that L/ZnO NPs were able to diminish lipid peroxidation, increase the activity of antioxidant enzymes, and reduce inflammation under oxidative stress. Consequently, it was able to reduce hyperglycemia, elevate insulin levels, and improve insulin resistance. Besides, L/ZnO NPs upregulate miR‐124, reduce C/EBPA mRNA, increase BCl‐2, and inhibit apoptosis. The results indicate that diabetes raises BBB permeability via tight junction protein decline, which is restored following L/ZnO NPs treatment. Luteolin/ZnO NPs regulate miR‐124 and microglia polarization by targeting C/EBPA and are expected to alleviate inflammatory injury via modulation of the redox‐sensitive signal transduction pathways. Luteolin/ZnO NPs have a novel target for the protection of the BBB and the prevention of neurological complications in diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalInsulinsMicroRNAsNeuroinflammatory DiseasesZinc OxideAnimalsRatsLuteolinNanoparticlesOxidative StressRNA, MessengerTight Junction Proteins

Stichwörter der Autor:innen

Luteolin/ZnO NPsblood brain-barrierdiabetesmiR-124

Substanzen

InsulinsLuteolinMicroRNAsMIRN124 microRNA, ratRNA, MessengerTight Junction ProteinsZinc Oxide

Autor:innen und Institutionen

  • Radiation Biology, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Health radiation research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.

ORCID-Profile: Enas M Moustafa, Fatma S M Moawed

Zitieren

APA

Moustafa, E. M., Moawed, F. S. M., & Elmaghraby, D. F. (2023). Luteolin/ ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA ‐124 by targeting C/ EBPA. Environmental Toxicology. https://doi.org/10.1002/tox.23903

Vancouver

Moustafa EM, Moawed FSM, Elmaghraby DF. Luteolin/ ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA ‐124 by targeting C/ EBPA. Environmental Toxicology. 2023. doi:10.1002/tox.23903

BibTeX
@article{Moustafa2023,
  author = {Moustafa, Enas M and Moawed, Fatma S M and Elmaghraby, Dina F},
  title = {Luteolin/ ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA ‐124 by targeting C/ EBPA},
  journal = {Environmental Toxicology},
  year = {2023},
  doi = {10.1002/tox.23903}
}
Kostenlos starten →